Elise April Str Chong MD

PubMed

• Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome.
  Omar Elghawy, Jonathan H Sussman, Austin G Yang, Colin J Thomas, Jordan S Carter
  JAMA Dermatology. 2025-04-02
• Prolonged Neurologic Symptoms Following Immune Effector Cell-Associated Neurotoxicity Syndrome in Patients With Large B-cell Lymphoma Treated With Chimeric Antigen Rec...
  Luke Maillie, Sunita D Nasta, Jakub Svoboda, Stefan K Barta, Elise A Chong
  Transplantation and Cellular Therapy. 2025-04-01
• Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP.
  Vincent Ni, Sunita D Nasta, Stefan K Barta, Stephen J Schuster, Elise A Chong
  Haematologica. 2025-04-01

Abstracts/Posters

• A Characterization of Bridging Therapies Leading up to Commercial CAR T-Cell Therapy
  Elise A. Chong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Identification and Validation of Predictive Biomarkers to CD19- and BCMA-Specific CAR T-Cell Responses in CAR T-Cell Precursors
  Elise A. Chong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Hospitalization Patterns with Commercial CAR T-Cell Therapy: A Single Institution Experience
  Elise A. Chong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Pembrolizumab and Copanlisib for the Treatment of Relapsed or Refractory Mature T-Cell Lymphomas
  Elise A. Chong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Use of Bendamustine for Lymphodepletion before Tisagenlecleucel (anti-CD19 CAR T cells) for Aggressive B-Cell Lymphomas
  Elise A. Chong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Outcomes for Double Hit Lymphoma Patients Identified Via Routine Vs Selective Testing for MYC Rearrangement
  Elise A. Chong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Mu...
  Elise A. Chong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• CD19-Directed CAR T-Cell (CTL019) Product Viability and Clinical Outcomes in Non-Hodgkin Lymphomas and B-Cell Acute Lymphoblastic Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018